As one of the world's leading deuterated technology companies, BOC Sciences is committed to building a complete technology chain for the research and development of deuterated drugs.
We focus on the development of deuterated products in the fields of life sciences and pharmaceuticals. Our scientists provide leading-edge deuterium expertise, including advanced analytical capabilities.
Our DCL™ platform enables the development of innovative drugs based on deuterium chemistry for multiple disease areas
Studies have shown that some deuterated derivatives can be used as drugs for the treatment and prevention of cardiovascular and cerebrovascular diseases.
Deuterium can block metabolic sites, reduce the generation of toxic metabolites, and improve the effectiveness and practicability of treating metabolic diseases.
Deuterated technology gives the active ingredient a good pharmacokinetic profile, showing therapeutic effects on neurodegenerative diseases.
Deuterated compounds are useful, for example, in therapy for the treatment of malignant hyperproliferative disorders or autoimmune diseases.
Both hospital diagnostic laboratories and university laboratories use deuterated compounds in their medical research, including oncology research.
Deuterated compounds can effectively improve the stability and efficacy of eye drops.